Find the BEST weed in...
Why Colorado is leading the way by embracing both medical and natural psychedelic options
May 17, 2026
Source:
Marijuana Moment
Marijuana Moment
The landscape for plant medicine and mental health treatment is shifting rapidly, and Colorado is leading the charge with a unique "both/and" approach that every enthusiast should keep an eye on. In a whirlwind 48-hour period, federal and state actions have paved two distinct roads for the future of psychedelics like psilocybin. First, a federal executive order is fast-tracking the FDA review process for certain breakthrough therapies, potentially cutting down wait times for new treatments from a year to just a couple of months.
At the same time, Colorado Governor Jared Polis signed Senate Bill 26-31, ensuring that as soon as the DEA reschedules these substances federally, Colorado is ready to roll them out through official medical channels. This means pharmaceutical-grade options could be available at specialized clinics sooner than anyone anticipated. However, the real win for our community is that Colorado isn't ditching its grassroots, voter-approved natural medicine framework (Proposition 122) in favor of a strictly clinical model.
While the pharmaceutical path offers a door for those seeking insurance-covered, doctor-supervised therapy, the natural medicine path protects the sacred, community-led, and ceremonial aspects of healing that many of us value. As Dr. Shannon Hughes points out, these aren't rival movements; they are different ways to reach the same goal of wellness.
For those of us navigating this space, this matters because it preserves choice. Whether you prefer a clinical setting or a community healing center, Colorado is fighting to keep both doors open. A pro-tip for locals: the next year of state rulemaking will define how these community programs actually look, so stay engaged and make your voice heard. It’s a beautiful moment for accessibility, proving that we can embrace modern science without losing the heart of traditional plant medicine culture. We just have to ensure our regulators keep their promises to fund and protect both paths.







